Irritable Bowel Syndrome Clinical Trial
Official title:
A Pilot Study on the Effect of Electroacupuncture on Functional Brain Mapping in Patients With Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is the most common digestive disorder that affects more than
5% of population in Hong Kong. However, there is no effective treatment of IBS using Western
Medicine. Acupuncture, a traditional therapeutic modality, has been used in China for
thousands of years for various pain disorders. In addition to analgesia, acupuncture has
also been shown to influence physiology of gastrointestinal tract. The investigators set out
to evaluate the therapeutic value of acupuncture in IBS. The investigators will study its
effects on rectal sensation and brain activity in patients with IBS.
All patients will be evaluated for study eligibility at visit 1 (baseline). Baseline
assessment includes individual IBS symptoms (pain/discomfort, bloating, constipation, and
diarrhea) as perceived by patients will be scored. The syndrome of IBS patients will also be
recorded and analyzed based on the Chinese medicine theories. All patients will then undergo
baseline rectal barostat for thresholds of rectal sensation. At visit 2, eligible patients
will be randomly assigned to either (1) electroacupuncture or (2) sham electroacupuncture
treatment groups. Functional Magnetic Resonance Imaging (fMRI) scanning will be performed
before, during and after the electroacupuncture or sham electroacupuncture treatment.
All patients will be evaluated for study eligibility at visit 1 (baseline). Baseline
assessment includes the following items:
1. Global symptom assessment: Based on Rome III Working Group recommendation, a clinical
outcome response measure is used in which patients are required to report "improved",
"the same" or "worsened" to the question "Do you have adequate symptom relief in the
past 7 days?"
2. Individual IBS symptoms: The individual IBS symptom (pain/discomfort, bloating,
constipation, and diarrhea) as perceived by patients will be scored in a 5-point scale
(0=none or asymptomatic; 1=mild with no limitation of normal activities; 2=moderate
with limitation of some normal activities; 3=intense and unable to carry out most
normal activities; 4=incapacitating symptom that are intolerable and unable to carry
out all normal activities).
3. Syndrome of Chinese medicine: The syndrome of IBS patients will be recorded and
analyzed based on the Chinese medicine theories. These symptoms involving: fatigue,
appetite, sense of mouth, quality of sleep, the coating of tongue, pulse, etc.
4. Quality of life (QOL) assessment: A disease-specific questionnaire- IBS Quality of Life
Scale (Chinese) will be used for assessment of QOL in response to treatment. The
questionnaire was locally validated, and was recently developed by our group.
5. Rectal barostat: The patients will be evaluated for the sensory threshold and maximum
tolerable threshold of rectum in response to balloon distension of rectum before the
acupuncture treatment.
At visit 2, eligible patients will be randomly assigned to either (1) electroacupuncture or
(2) sham electroacupuncture. During the treatment, the patient will receive fMRI to evaluate
the cerebral cortical activity in response to balloon distension of rectum. Three sets of
real-time functional brain mapping using fMRI will be performed during rectal balloon
distensions at maximum tolerable pressure at the following time points:
1. 10 minutes after acupuncture needle insertion before delivery of electrical stimulation
2. 15 minutes after electrical stimulation begins (electrical stimulation continues during
MRI)
3. Immediately after electrical stimulation stops before removal of acupuncture needle
Rectal barostat:
The barostat device contains a built-in computer system that can be programmed to
automatically perform distensions of balloon with fixed time lags and bag pressure
increments. Variation in balloon volume in a constant pressure reflects the change in tone
and compliance of the visceral wall. Furthermore, through a programmed variation in
intraballoon pressure, the sensory threshold of subject can be evaluated.
The patient is instructed to take low residue diet 2 days prior to barostat. On the day
before barostat, bowel preparation is performed by ingestion of 4 liters of polyethylene
glycol solution in 2 divided doses. After a 12-hour fast, the participant is positioned in
supine position on MRI table. A barostat bag is inserted into the rectum. The barostat
device is connected to the barostat catheter using a low compliance PVC tubing. The
participant will remain alone in MRI cubicle during the whole experiment but a speaker and
microphone system allows communication with the investigator. He/she is also provided a
squeeze bulb to signify pain. Repeated squeezing of the bulb signifies request for
termination of procedure.
Phasic isobaric rectal distensions are performed automatically using ascending method of
limits (AML) protocol with successive increments of 4 mm Hg (40-second duration) alternating
with intermittent periods of bag deflation (40 seconds). During each distension phase, the
participant is requested to report the perception ratings by pressing on the perception
panel of barostat device with the following scale: (1) no sensation (2) the first sensation
of balloon distension, (3) desire for defecation, (4) maximum tolerable sensation. The
procedure will be stopped when pain or maximum tolerable sensation is reported. The sensory
threshold is defined as lower limit of the bag pressure that evokes the first sensation of
balloon distension. The pain threshold is defined as pressure that elicits a "pain" response
or maximum tolerable sensation.
Electroacupuncture Treatment:
Treatment will be performed by a single licensed acupuncturist. Both the patient and the
investigator are unaware of the treatment assigned. A specially designed copper needle
(0.22x4mm), which can be used safely in MRI suite, will be inserted through a plaster over
the respective acupoints, under which a plastic ring will be positioned, connected with
electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair) through wires with
stimulation frequency of 150Hz, lasting for 30 minutes. For sham acupuncture, the needle
will be positioned at 2cm away from the true respective acupoints., the same electric
stimulation will be the same as real acupuncture treatment. The treatment will be given by
an independent acupuncturist who is not involved in the data acquisition and analysis.
Points for acupuncture treatment are chosen to regain the balance of liver qi stagnation and
strengthen the spleen:
Anatomical location (Function according to TCM)
1. SP06:3cm above the medial malleolus dorsal tibial rim (Strengthens spleen and stomach)
2. ST25:2cm lateral to the umbilicus (Strengthens spleen and stop diarrhea)
3. ST36:5cm below patella, 2 cm lateral of the tibial rim (Strengthens spleen and stomach)
4. ST37:3cm below ST36 (Strengthens spleen and stop diarrhea)
Functional MRI:
BOLD imaging is performed with a 3-T MRI scanner (Philips Achieva 3.0T, X series, Quasar
Dual MRI system). Each study consists of axial T1-weighted spin echo images (matrix of at
least 192 × 256) covering the whole brain for anatomical correlation. Functional scan is
performed using a single-shot echo planar pulse sequence in an interleaved multislice format
with a field of view of 24 cm and a matrix size of at least 64 × 64, resulting in a in-plane
resolution of 3.75 × 3.75. The pulse sequence parameters include a 90° flip-angle with a TE
(time to echo)/TR (repetition time) of 60 ms/4000 ms. Each paradigm consists of 5 periods.
Each period will consist of rest and stimulation (tube inflation causing rectal distension).
In each period, 50 dynamics are performed. Each dynamic will last for 2 seconds. The scans
will be performed with the rectal tube inflated to render:
1. Desire for defecation, and
2. Painful sensation, as determined by the barostat study at baseline visit within one
week before MRI scanning.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03720314 -
Microbiota Profiling in IBS
|
||
| Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
| Completed |
NCT05213910 -
Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains
|
N/A | |
| Recruiting |
NCT05985018 -
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
|
N/A | |
| Completed |
NCT04486469 -
Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study.
|
N/A | |
| Completed |
NCT06407609 -
Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS
|
N/A | |
| Completed |
NCT04656730 -
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
|
Phase 4 | |
| Completed |
NCT04145856 -
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico
|
Phase 4 | |
| Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
| Active, not recruiting |
NCT03586622 -
One Year Home Monitoring and Treatment of IBS Patients
|
N/A | |
| Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
| Not yet recruiting |
NCT06369753 -
Visible Abdominal Distension
|
N/A | |
| Not yet recruiting |
NCT05157867 -
In Vivo Effects of Amylase Trypsin Inhibitors
|
N/A | |
| Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
| Recruiting |
NCT05001997 -
Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome
|
N/A | |
| Recruiting |
NCT02953171 -
Probiotics in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT03266068 -
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
|
||
| Completed |
NCT02977975 -
Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT02980406 -
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
|
N/A | |
| Completed |
NCT03318614 -
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
|
Phase 2/Phase 3 |